EditorialFollowing the completion of the human genome sequence
and the concomitant technological innovations required for
whole genome analyses, the last decade has witnessed an
explosion of data and information concerning the posttranscriptional
regulation of gene expression, in both pathological
and nonpathological contexts. Among the most notable
posttranscriptional events studied are the widespread usage
of alternative splicing, the pleiotropic regulatory roles of
miRNAs, and breakthroughs in the understanding of the
control of gene expression by noncoding RNA transcripts.
In this special issue of this journal, the spotlight is centered
on the role that various mechanisms of posttranscriptional
regulation—and the RNA binding proteins (RBPs) that
control them—play in cancer biology